Page last updated: 2024-11-12

dihydro-n-caffeoyltyramine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dihydro-N-caffeoyltyramine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16119668
CHEMBL ID208465
CHEBI ID186951
SCHEMBL ID2378518
MeSH IDM0446949

Synonyms (12)

Synonym
CHEMBL208465
dihydro-n-caffeoyltyramine
CHEBI:186951
3-(3,4-dihydroxyphenyl)-n-[2-(4-hydroxyphenyl)ethyl]propanamide
3-(3,4-dihydroxyphenyl)-n-[2-(4-hydroxyphenyl)ethyl]propanimidic acid
SCHEMBL2378518
501939-19-1
3,4-dihydroxy-n-(2-(4-hydroxyphenyl)ethyl)benzenepropanamide
benzenepropanamide, 3,4-dihydroxy-n-(2-(4-hydroxyphenyl)ethyl)-
9BS8U8P69Q ,
unii-9bs8u8p69q
p-coumaric acid derivative 4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
catecholsAny compound containing an o-diphenol component.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID731498Antioxidant activity assessed as inhibition of xanthine-xanthine oxidase generated superoxide anion radical production by NBT reduction assay2013Journal of natural products, Jan-25, Volume: 76, Issue:1
Neolignanamides, lignanamides, and other phenolic compounds from the root bark of Lycium chinense.
AID731499Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins2013Journal of natural products, Jan-25, Volume: 76, Issue:1
Neolignanamides, lignanamides, and other phenolic compounds from the root bark of Lycium chinense.
AID263690Toxicity in rat at 2 g/kg, po2006Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8
Analogues of N-hydroxycinnamoylphenalkylamides as inhibitors of human melanocyte-tyrosinase.
AID263688Inhibitory activity against tyrosinase at 100uM2006Bioorganic & medicinal chemistry letters, Apr-15, Volume: 16, Issue:8
Analogues of N-hydroxycinnamoylphenalkylamides as inhibitors of human melanocyte-tyrosinase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.43

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.43 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.43)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]